Skip to content
Search

Latest Stories

Workers strike for pay hike at Ashok Leyland's UK subsidiary

AROUND 500 workers at the Optare bus manufacturing plant in Sherburn-in-Elmet, North Yorkshire, are striking for pay increase.

Optare is a subsidiary of the Indian vehicle manufacturer Ashok Leyland, run by the Hinduja group.


The workers said that there was no pay hike at the plant for the last two years.

The 100 Unite union members at the plant voted by a 73 percent majority for action. From November 17, they escalated action by holding four-day strikes which are continuing.  are employed at the site.

According to reports, Optare reneged on its promise to implement a pay rise from November 2019. The union had been in negotiations with the company for the previous 18 months.

In 2010, Ashok Leyland group acquired a 26 per cent share in Optare, and increased it to 75 per cent in 2011.

It now has a 99 per cent share and total control. Under Ashok Leyland, Optare closed its East Lancashire site in 2012 after moving further out from its east Leeds site to a newly built facility in Sherburn-in-Elmet in 2011.

Ashok Leyland, the one-time subsidiary of British Leyland, is headquartered in Chennai, India. It is world’s third largest bus manufacturer, 10th largest truck producer and India's second largest commercial vehicles maker.

In 2019, Optare reported around £49 million revenues, almost doubling the previous year’s, but showed a near £9m loss after tax.

In May this year, Optare, along with the UK other major bus manufacturers, Wrightbus, and Alexander Dennis, have requested for government funding to mitigate the impact of Covid-19.

“Without immediate support, future orders will not be forthcoming, putting over 10,000 jobs and apprenticeship opportunities at risk," they said.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less